Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Citialfa 1000mg Injection

Prescription Icon
Prescription Required

Marketer

Alniche Life Sciences Pvt Ltd

Salt Composition

Citicoline (1000mg)

Overview Citialfa 1000mg Injection

NeuroMend 1000mg Injection treats stroke, head trauma, Alzheimer's disease, and Parkinson's-related dementia. It safeguards brain neurons from harm and promotes their repair, thus enhancing cognitive function. Administered intravenously by a healthcare provider only (not for self-injection), it's used when oral medication is infeasible. Follow your doctor's prescribed dosage and regimen; take any missed dose promptly. Potential side effects include hypotension, abdominal discomfort, diarrhea, arrhythmia, skin rash, sleep disturbances, and worsening numbness in affected limbs. Injection site reactions (pain, redness, swelling) may occur but are usually transient. Report persistent or bothersome side effects to your physician. Prior to treatment, disclose any kidney issues, seizure history (epilepsy), or current medications. Dosage is tailored to age and condition. Inform your doctor of pregnancy, pregnancy plans, or breastfeeding before commencing treatment.

Uses of Citialfa 1000mg Injection

Managing stroke, head trauma, Alzheimer's, and Parkinson's-related dementia.

Major Benefits of Citialfa 1000mg Injection:

This medication will be administered by your physician or their qualified assistant; self-medication is strongly discouraged.

Common Side effects of Citialfa 1000mg Injection:

  • Injection site reactions (pain, swelling, redness)
  • Decreased blood pressure
  • Arrhythmia (irregular heartbeats)
  • Stomach pain
  • Diarrhea
  • Insomnia (difficulty in sleeping)
  • Rash
  • Peripheral neuropathy (tingling and numbness of feet and hand)

How to use Citialfa 1000mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Citialfa 1000mg Injection works:

Neuropathic support is provided by Citialfa 1000mg Injection, which promotes nerve cell health. Its mechanism involves bolstering nerve cell survival and mitigating damage through the synthesis of key neurochemicals, such as phosphatidylcholine and acetylcholine. Additionally, it lessens the accumulation of free fatty acids around injured nerve tissue.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Citialfa 1000mg Injection may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on the use of Citialfa 1000mg Injection in pregnancy are lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Citialfa 1000mg Injection use while breastfeeding is absent. Seek medical advice.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Citialfa 1000mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

For individuals with kidney impairment, administration of Citialfa 1000mg Injection requires careful monitoring. Dosage modification of Citialfa 1000mg Injection may be necessary. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Citialfa 1000mg Injection to individuals with hepatic impairment. Physician consultation is recommended.

What if you forget to take Citialfa 1000mg Injection :

NA

Facts to Know About Citialfa 1000mg Injection

LabelValue
Type of Compound Diphosphate pyrimidine ribonucleotide
Potential for Dependence None.
Type of Treatment Nervous system.
Mechanism of Action Cognitive enhancer

FAQs on Citialfa 1000mg Injection

A choline-based injectable solution, Citialfa 1000mg, provides this vital nutrient naturally found within the body. Its action safeguards brain neurons from harm and facilitates their repair. Consequently, it enhances cognitive abilities, including memory, learning, and information processing, particularly beneficial in Alzheimer's disease management.
Research is lacking on the interaction between alcohol and Citialfa 1000mg Injection therapy. Given that Citialfa 1000mg Injection treats conditions such as stroke, Alzheimer's disease, Parkinson's disease, head trauma, and age-related cognitive decline, abstaining from alcohol is recommended.
Citialfa 1000mg Injection is inappropriate for student use. Research indicates its efficacy is limited to age-related memory impairment, memory deficits following stroke, and Alzheimer's disease. Furthermore, pediatric data on its use is lacking.
For ischemic stroke patients, oral administration of 1000mg Citialfa Injection may facilitate full recovery within three months. Intravenous administration of 1000mg Citialfa Injection, initiated within twelve hours of stroke onset or daily for seven days post-stroke, may expedite recovery.
Citialfa 1000mg Injection
176
MRP 215
18% off